Barbara Segarra-Vazquez, DHSc, will participate in a conversation about how patients and patient advocates have steadily expanded their roles in clinical trial design, drug development and approvals, and other research processes.

Joan Brugge, PhD, will review findings that provide new understanding about the role of chromosomal alterations in breast cancer development.

Anne Welsh, PhD, will help equip physicians and researchers with tools to foster more supportive and collaborative environments in academic medicine.

Leif Ellisen, MD, PhD, will moderate a session on new and emerging spatial omic approaches to improving response prediction, prognostication, and mechanistic understanding in breast cancer.

Armando E. Giuliano, MD, will receive the William L. McGuire Memorial Lecture Award at SABCS 2025 in recognition of his transformative work on sentinel lymph node biopsy in breast cancer.

Seema A. Khan, MD, will moderate a special session at SABCS 2025 on how alcohol consumption and obesity impact breast cancer risk, and how lifestyle changes may reduce risk.

Steffi Oesterreich, PhD, will co-moderate a special session at SABCS 2025 that will highlight lobular breast cancer subtype classification, biomarkers, therapeutic targets, and more.

Ann Partridge, MD, MPH, will moderate a special session at SABCS 2025 that will focus on the unique biological and social circumstances of younger women with breast cancer.

Frederick Howard, MD, will moderate an SABCS 2025 educational session that will chart the roadmap of AI in breast cancer — where it is currently, which direction it might be going, and what tools should be used to evaluate its contributions.

Sessions at the 48th annual San Antonio Breast Cancer Symposium will explore the current applications of and questions around liquid biopsy in breast cancer, as well as what’s on the horizon for circulating tumor DNA (ctDNA) and how it might influence future clinical trials.